These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2753069)

  • 1. Hepatic extraction of morphine is impaired in cirrhosis.
    Crotty B; Watson KJ; Desmond PV; Mashford ML; Wood LJ; Colman J; Dudley FJ
    Eur J Clin Pharmacol; 1989; 36(5):501-6. PubMed ID: 2753069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
    Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
    Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cimetidine on hepatic drug elimination in cirrhosis.
    Nelson DC; Avant GR; Speeg KV; Hoyumpa AM; Schenker S
    Hepatology; 1985; 5(2):305-9. PubMed ID: 3979962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M; Watanabe G
    Hepatogastroenterology; 2000; 47(36):1669-74. PubMed ID: 11149029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
    Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
    Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites.
    Lay CS; Tsai YT; Kong CW; Lee FY; Chang TT; Lin HC; Yang CM; Lee SD; Chiang BN; Lo KJ
    Clin Pharmacol Ther; 1988 Oct; 44(4):453-7. PubMed ID: 3168396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction of 125I-albumin microaggregates from portal blood. An index of functional portal blood supply in cirrhotics.
    Huet PM; Marleau D; Lavoie P; Viallet A
    Gastroenterology; 1976 Jan; 70(1):74-81. PubMed ID: 1245287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
    Birnie GG; Fitzsimons CP; Czarnecki D; Cooke A; Scobie G; Brodie MJ
    Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.
    Herz R; Rössle M; Bonzel T; Keller E; Gerok W
    Klin Wochenschr; 1984 Aug; 62(16):759-64. PubMed ID: 6482311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method.
    Molino G; Avagnina P; Belforte G; Bircher J
    J Lab Clin Med; 1998 May; 131(5):393-405. PubMed ID: 9605103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
    Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
    Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization?
    Ott P; Clemmesen O; Keiding S
    Dig Dis Sci; 2000 Feb; 45(2):359-65. PubMed ID: 10711452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease.
    Gadano A; Hadengue A; Vachiery F; Moreau R; Sogni P; Soupison T; Yang S; Cailmail S; Lebrec D
    J Gastroenterol Hepatol; 1997 Feb; 12(2):167-71. PubMed ID: 9083919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
    Saudek F; Morávek J; Modr Z
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.